ReviewInternational journal of molecular sciences2017

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs.

Luyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.